Our previous research revealed that SUMOylation of lysine residue 110 (K110) of NRF2 reduces ROS levels, promotes de novo serine synthesis, and maintains hepatocellular carcinoma tumorigenesis [23]. The gene discussed is NFE2L2; the disease is hepatocellular carcinoma.